SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 47 filers reported holding SQZ BIOTECHNOLOGIES CO in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | -83.7% | 12,357 | -69.5% | 0.00% | – |
| Q4 2021 | $361,000 | -69.6% | 40,469 | -50.9% | 0.00% | -100.0% |
| Q3 2021 | $1,188,000 | -0.7% | 82,373 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $1,196,000 | +2966.7% | 82,791 | +2807.0% | 0.00% | – |
| Q1 2021 | $39,000 | -57.1% | 2,848 | -8.8% | 0.00% | – |
| Q4 2020 | $91,000 | – | 3,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 1,330,889 | $984,857 | 0.08% |
| Artal Group S.A. | 1,606,309 | $1,189 | 0.07% |
| Sandy Cove Advisors, LLC | 51,707 | $38,263 | 0.03% |
| MAVERICK CAPITAL LTD | 1,068,155 | $790,435 | 0.02% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,862,708 | 0.01% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $2,041,045 | 0.01% |
| RBF Capital, LLC | 127,930 | $94,000 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 14,000 | $10 | 0.00% |
| Ergoteles LLC | 64,215 | $47,519 | 0.00% |
| Baldrige Asset Management LLC | 5,000 | $4 | 0.00% |